UniProt ID | TRDN_HUMAN | |
---|---|---|
UniProt AC | Q13061 | |
Protein Name | Triadin | |
Gene Name | TRDN | |
Organism | Homo sapiens (Human). | |
Sequence Length | 729 | |
Subcellular Localization |
Cell membrane . Sarcoplasmic reticulum membrane Single-pass type II membrane protein . |
|
Protein Description | Contributes to the regulation of lumenal Ca2+ release via the sarcoplasmic reticulum calcium release channels RYR1 and RYR2, a key step in triggering skeletal and heart muscle contraction. Required for normal organization of the triad junction, where T-tubules and the sarcoplasmic reticulum terminal cisternae are in close contact (By similarity). Required for normal skeletal muscle strength. Plays a role in excitation-contraction coupling in the heart and in regulating the rate of heart beats.. | |
Protein Sequence | MTEITAEGNASTTTTVIDSKNGSVPKSPGKVLKRTVTEDIVTTFSSPAAWLLVIALIITWSAVAIVMFDLVDYKNFSASSIAKIGSDPLKLVRDAMEETTDWIYGFFSLLSDIISSEDEEDDDGDEDTDKGEIDEPPLRKKEIHKDKTEKQEKPERKIQTKVTHKEKEKGKEKVREKEKPEKKATHKEKIEKKEKPETKTLAKEQKKAKTAEKSEEKTKKEVKGGKQEKVKQTAAKVKEVQKTPSKPKEKEDKEKAAVSKHEQKDQYAFCRYMIDIFVHGDLKPGQSPAIPPPLPTEQASRPTPASPALEEKEGEKKKAEKKVTSETKKKEKEDIKKKSEKETAIDVEKKEPGKASETKQGTVKIAAQAAAKKDEKKEDSKKTKKPAEVEQPKGKKQEKKEKHVEPAKSPKKEHSVPSDKQVKAKTERAKEEIGAVSIKKAVPGKKEEKTTKTVEQEIRKEKSGKTSSILKDKEPIKGKEEKVPASLKEKEPETKKDEKMSKAGKEVKPKPPQLQGKKEEKPEPQIKKEAKPAISEKVQIHKQDIVKPEKTVSHGKPEEKVLKQVKAVTIEKTAKPKPTKKAEHREREPPSIKTDKPKPTPKGTSEVTESGKKKTEISEKESKEKADMKHLREEKVSTRKESLQLHNVTKAEKPARVSKDVEDVPASKKAKEGTEDVSPTKQKSPISFFQCVYLDGYNGYGFQFPFTPADRPGESSGQANSPGQKQQGQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
11 | Phosphorylation | ITAEGNASTTTTVID EEECCCCCEEEEEEE | 30.22 | 30576142 | |
15 | Phosphorylation | GNASTTTTVIDSKNG CCCCEEEEEEECCCC | 17.24 | 18187866 | |
27 | Phosphorylation | KNGSVPKSPGKVLKR CCCCCCCCCCCEEEE | 32.58 | 18452278 | |
75 | N-linked_Glycosylation | FDLVDYKNFSASSIA HHHCCCCCCCHHHHH | 29.85 | UniProtKB CARBOHYD | |
77 | Phosphorylation | LVDYKNFSASSIAKI HCCCCCCCHHHHHHH | 36.31 | 19413330 | |
86 | Phosphorylation | SSIAKIGSDPLKLVR HHHHHHCCCHHHHHH | 39.26 | 22673903 | |
160 | Phosphorylation | KPERKIQTKVTHKEK CCCHHHCHHCCHHHH | 30.84 | 23312004 | |
195 | Acetylation | EKIEKKEKPETKTLA HHHHHHCCHHHHHHH | 57.97 | 7408777 | |
199 | Acetylation | KKEKPETKTLAKEQK HHCCHHHHHHHHHHH | 39.62 | 19657435 | |
220 | Acetylation | KSEEKTKKEVKGGKQ HHHHHHHHHHCCCHH | 73.33 | 7692099 | |
226 | Acetylation | KKEVKGGKQEKVKQT HHHHCCCHHHHHHHH | 65.04 | 20167786 | |
229 | Acetylation | VKGGKQEKVKQTAAK HCCCHHHHHHHHHHH | 52.84 | 20167786 | |
233 | Phosphorylation | KQEKVKQTAAKVKEV HHHHHHHHHHHHHHH | 23.90 | 28258704 | |
303 | O-linked_Glycosylation | TEQASRPTPASPALE CHHCCCCCCCCHHHH | 30.31 | OGP | |
325 | Phosphorylation | KAEKKVTSETKKKEK HHHHHCCHHHHHHHH | 46.38 | - | |
339 | Phosphorylation | KEDIKKKSEKETAID HHHHHHHHHHHCCCC | 63.88 | 26437602 | |
343 | Phosphorylation | KKKSEKETAIDVEKK HHHHHHHCCCCCCCC | 39.73 | 26437602 | |
356 | Phosphorylation | KKEPGKASETKQGTV CCCCCCCCCCCCHHH | 49.65 | 29083192 | |
358 | Phosphorylation | EPGKASETKQGTVKI CCCCCCCCCCHHHHH | 26.60 | 29083192 | |
362 | Phosphorylation | ASETKQGTVKIAAQA CCCCCCHHHHHHHHH | 19.01 | 29083192 | |
409 | Phosphorylation | KHVEPAKSPKKEHSV HCCCCCCCCCCCCCC | 44.02 | 26437602 | |
415 | Phosphorylation | KSPKKEHSVPSDKQV CCCCCCCCCCCHHHH | 36.49 | 26437602 | |
418 | Phosphorylation | KKEHSVPSDKQVKAK CCCCCCCCHHHHHHH | 56.11 | 26437602 | |
437 | Phosphorylation | KEEIGAVSIKKAVPG HHHHCCCEEEECCCC | 28.31 | 28258704 | |
439 | Ubiquitination | EIGAVSIKKAVPGKK HHCCCEEEECCCCCC | 27.46 | - | |
446 | Ubiquitination | KKAVPGKKEEKTTKT EECCCCCCCCCCCHH | 76.62 | - | |
463 | Phosphorylation | QEIRKEKSGKTSSIL HHHHHHHCCCCCHHH | 46.76 | - | |
466 | Phosphorylation | RKEKSGKTSSILKDK HHHHCCCCCHHHCCC | 31.09 | - | |
468 | Phosphorylation | EKSGKTSSILKDKEP HHCCCCCHHHCCCCC | 36.85 | 24719451 | |
477 | Ubiquitination | LKDKEPIKGKEEKVP HCCCCCCCCCCCCCC | 74.72 | - | |
486 | Phosphorylation | KEEKVPASLKEKEPE CCCCCCCCCCCCCCC | 33.63 | - | |
496 | Ubiquitination | EKEPETKKDEKMSKA CCCCCCHHHHHHHHC | 77.77 | - | |
575 | Acetylation | VTIEKTAKPKPTKKA EEEECCCCCCCCCCH | 59.82 | 134035 | |
581 | Acetylation | AKPKPTKKAEHRERE CCCCCCCCHHHCCCC | 62.58 | 134033 | |
591 | Phosphorylation | HREREPPSIKTDKPK HCCCCCCCCCCCCCC | 47.64 | 22985185 | |
605 | Phosphorylation | KPTPKGTSEVTESGK CCCCCCCCCCCCCCC | 38.44 | 26437602 | |
610 | Phosphorylation | GTSEVTESGKKKTEI CCCCCCCCCCCCCCC | 46.69 | 26437602 | |
615 | Phosphorylation | TESGKKKTEISEKES CCCCCCCCCCCHHHH | 47.64 | 28258704 | |
625 | Trimethylation | SEKESKEKADMKHLR CHHHHHHHHHHHHHH | 54.12 | - | |
625 | Methylation | SEKESKEKADMKHLR CHHHHHHHHHHHHHH | 54.12 | 23644510 | |
642 | Phosphorylation | KVSTRKESLQLHNVT HHHHHHHHHHHHCCC | 25.17 | 26437602 | |
647 | N-linked_Glycosylation | KESLQLHNVTKAEKP HHHHHHHCCCCCCCC | 52.31 | UniProtKB CARBOHYD | |
667 | Phosphorylation | DVEDVPASKKAKEGT CHHHCCHHHHHCCCC | 28.72 | 26437602 | |
674 | Phosphorylation | SKKAKEGTEDVSPTK HHHHCCCCCCCCCCC | 30.06 | - | |
678 | Phosphorylation | KEGTEDVSPTKQKSP CCCCCCCCCCCCCCC | 38.89 | 17924679 | |
680 | Phosphorylation | GTEDVSPTKQKSPIS CCCCCCCCCCCCCCC | 38.30 | 17924679 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRDN_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRDN_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRDN_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
615441 | Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness (CPVT5) | |||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-678 AND THR-680, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-409, AND MASSSPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-15, AND MASSSPECTROMETRY. |